HOLLISTON, Mass., Sept. 16, 2010 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, today announced that its President, David Green, will present at the UBS 2010 Life Sciences Conference on Tuesday, September 21, 2010 at 4:00 p.m. local time at the Grand Hyatt Hotel in New York. To hear a live webcast of our presentation, visit the "Events and Presentations" tab on our Company website at www.harvardbioscience.com or the live webcast can be accessed at http://cc.talkpoint.com/ubsx001/092110a_lv/?entity=158_47BWFGJ. Mr. Green's presentation will be available on our website by clicking on the investor presentation icon. Our presentation will be available by replay shortly after the actual presentation time and will be available and archived for one year. The presentation will cover the historical and expected future performance of the business. There will be a question and answer session following the presentation. Some of the information to be presented by Mr. Green or provided in response to questions may contain information that has not previously been disclosed. Additionally, any material financial or other statistical information presented in our presentation or in the question and answer session that has not been previously disclosed will be archived and available in the Investor Relations section of our website. About Harvard Bioscience Harvard Bioscience ("HBIO") is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments, used to advance life science research and regenerative medicine. HBIO sells its products to thousands of researchers in over 100 countries primarily through its 850 page catalog (and various other specialty catalogs), its website, through distributors, including GE Healthcare, Thermo Fisher Scientific and VWR, and via our field sales organization. HBIO has sales and manufacturing operations in the United States, the United Kingdom, Germany and Spain with additional facilities in France and Canada. For more information, please visit www.harvardbioscience.com. For investor inquiries, please call (508) 893-8066. Press releases may be found on our web site, http://www.harvardbioscience.com.
CONTACT: Harvard Bioscience, Inc. David Green, President 508 893 8999 Fax: 508 429 8478 firstname.lastname@example.org Chane Graziano, CEO email@example.com Tom McNaughton, CFO firstname.lastname@example.org